MiMedx (MDXG) CEO Joseph Capper Receives Restricted Stock Award

What Happened
Joseph H. Capper, CEO of MiMedx Group, Inc. (MDXG), received equity awards reported on 2026-03-04: 371,094 shares were granted as restricted stock (acquired at $0) and an additional 310,574 derivative shares (acquired at $0). These were reported on a Form 4 filed 2026-03-06. These are awards/compensation — not open-market purchases or sales — and no cash changed hands at grant.

Key Details

• Transaction date: March 4, 2026; Form 4 filed March 6, 2026 (reporting period: 2026-03-04). Filing appears timely.
• Grants: 371,094 restricted shares @ $0.00 (award); 310,574 derivative shares @ $0.00 (award/derivative). Total shares granted on that date = 681,668.
• Vesting and related footnotes:
  • F1: The 371,094 restricted shares vest in full on the third anniversary of the grant, subject to continued employment.
  • F3: (Referenced) options generally vest 25% each year on anniversaries if and when option grants apply.
  • F2: Separately notes an aggregate of 4,032 shares previously acquired (July 31, 2025 and Jan 30, 2026) under the company Employee Stock Purchase Plan.
• Shares owned after transaction: not specified in the provided filing summary.
• No sales, option exercises for cashless sale, or tax-withholding sales were reported in this filing.

Context
These awards are typical executive compensation/retention grants. Because the restricted/derivative shares vest over time, they are not immediately tradable and do not represent an immediate market purchase or sale. Awards at $0 reflect compensation value at grant rather than a cash investment by the insider; they should be viewed as part of pay and retention rather than an explicit personal buy/sell signal.